Public Health

In this COVID-19 roundup, researchers report on the risk of health issues and death among patients hospitalized with COVID-19 at 3 year-follow-up, the widespread overuse of antibiotics among patients with...

In a population-based, cross-sectional study, researchers examined US women aged 20 to 49 years who were diagnosed with primary invasive breast cancer from 2000 through 2019.

In this respiratory disease roundup, researchers report on the efficacy of nirmatrelvir-ritonavir for treating Long COVID, the CDC updates recommendations on “triple threat” vaccines for respiratory virus...

Breast cancer deaths have fallen by 44% since 1989, according to a new report by the American Cancer Society.

Researchers aimed to describe the most common symptoms of long COVID and the progression of symptoms over time. They presented their findings at IDWeek 2023 in Boston, Massachusetts.

Two randomized, double-blind studies demonstrated that a new antipsychotic treatment for adult patients with schizophrenia may lead to a meaningful reduction in symptoms.

The nasal spray is the first vaccine for the prevention of influenza that does not need to be administered by a health care provider.

The first nalmefene hydrochloride auto-injector is another emergency treatment tool to reverse known or suspected opioid overdose.

The nasal spray is the first FDA-approved epinephrine product for the treatment of anaphylaxis not to be administered by injection.

The nasal spray is the first FDA-approved epinephrine product for the treatment of anaphylaxis not to be administered by injection.